期刊文献+

化痰丸治疗痰热壅肺型支气管扩张症的临床观察 被引量:1

Clinical observation of Huatan pills in the treatment of bronchiectasis of phlegm-heat obstructing lung type
下载PDF
导出
摘要 目的观察院内制剂化痰丸治疗痰热壅肺型支气管扩张症的临床疗效。方法80例痰热壅肺型支气管扩张症患者,随机分为对照组和治疗组,每组40例。对照组采用常规西药治疗,治疗组在常规西药治疗的基础上加用化痰丸治疗。比较两组患者治疗前后的白细胞计数(WBC)、C反应蛋白(CRP)、钙素原(PCT)水平及中医证候积分,临床疗效。结果治疗后,两组患者的WBC、CRP、PCT水平均较本组治疗前降低,且治疗组患者的WBC、PCT水平均低于对照组,差异均具有统计学意义(P<0.05);两组患者治疗后的CRP水平比较,差异无统计学意义(P>0.05)。治疗后,两组患者的中医证候积分均较本组治疗前降低,且治疗组(8.95±2.58)分低于对照组的(12.84±3.12)分,差异均具有统计学意义(P<0.05)。治疗组总有效率为90.0%,高于对照组的72.5%,差异具有统计学意义(P<0.05)。结论化痰丸联合常规西医药治疗痰热壅肺型支气管扩张症效果明显,值得推广使用。 Objective To observe the clinical efficacy of hospital preparation Huatan pills in the treatment of bronchiectasis of phlegm-heat obstructing lung type.Methods A total of 80 patients with bronchiectasis of phlegm-heat obstructing lung type were randomly divided into control group and treatment group,with 40 cases in each group.The control group was treated by conventional Western medicine,and the treatment group was treated by Huatan pills on the basis of conventional Western medicine.The white blood cell(WBC)count,C-reactive protein(CRP),procalcitonin(PCT)levels and traditional Chinese medicine syndrome integral before and after treatment,and clinical efficacy were compared between the two groups.Results After treatment,the levels of WBC,CRP and PCT of the two groups were lower than those before treatment of the same group,and WBC,PCT levels of the treatment group were lower than those of the control group,and the difference was statistically significant(P<0.05).After treatment,there was no statistically significant difference in CRP level between the two groups(P>0.05).After treatment,the traditional Chinese medicine syndrome integral of the two groups were lower than those before treatment of the same group,and the treatment group(8.95±2.58)points was lower than that of the control group(12.84±3.12)points,and the difference was statistically significant(P<0.05).The total effective rate of the treatment group was 90.0%,which was higher than that of the control group 72.5%,and the difference was statistically significant(P<0.05).Conclusion Huatan pills combined with conventional Western medicine shows obviously effect for bronchiectasis of phlegm-heat obstructing lung type,and it is worthy of promotion and application.
作者 王亚琼 祝庆华 唐明文 WANG Ya-qiong;ZHU Qing-hua;TANG Ming-wen(Shenzhen Hospital of Traditional Chinese Medicine,Shenzhen 518033,China)
机构地区 深圳市中医院
出处 《中国实用医药》 2020年第16期141-143,共3页 China Practical Medicine
基金 深圳市“医疗卫生三名工程项目”(项目编号:SZSM201812063)项目名称:中日友好医院晁恩祥国医大师中医肺病团队。
关键词 痰热壅肺 支气管扩张症 化痰丸 Phlegm-heat obstructing lung Bronchiectasis Huatan pills
  • 相关文献

参考文献2

二级参考文献20

  • 1王吉耀.内科学[M].第2版.北京:人民卫生出版社,2011:528.
  • 2叶任高.内科学[M]5版[M].北京:人民卫生出版社,2000.961.
  • 3Woodhead M,Blasi F,Ewig S. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases.Guidelines for the management of adult lower respiratory tract infections[J].European Respiratory Journal,2005,(06):1138-1180.
  • 4Woodhead M,Blasi F,Ewig S. Guidelines for the management of adult lower respiratory tract infections--full version[J].Clinical Microbiology and Infection,2011,(Suppl 6):E1-E59.
  • 5Pasteur MC,Bilton D,Hill AT. British Thoracic Society guideline for non-CF bronchiectasis[J].Thorax,2010,(Suppl 1):il-i58.
  • 6Weycker D,Edelsberg J,Oster G. Prevalence and economic burden of bronchiectasis[J].American Journal of Respiratory and Critical Care Medicine,2004.A330.
  • 7Twiss J,Metcalfe R,Edwards E. New Zealand national incidence of bronchiectasis "too high" for a developed country[J].Archives of Disease in Childhood,2005,(07):737-740.doi:10.1136/adc.2004.066472.
  • 8Weycker D,Edelsberg J,Oster G. Prevalence and economic burden of bronchiectasis[J].Clinical Pulmonary Medicine,2005,(4):205-209.doi:10.1097/01.cpm.0000171422.98696.ed.
  • 9Crofton J. Bronchiectasis[A].Oxford:Blackwell Scientific Publication,1981.417-430.
  • 10Patel IS,Vlahos I,Wilkinson TM. Bronchiectasis,exacerbation indices,and inflammation in chronic obstructive pulmonary disease[J].American Journal of Respiratory and Critical Care Medicine,2004,(04):400-407.

共引文献263

同被引文献33

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部